Global Pirfenidone Market Growth 2025-2031
The global Pirfenidone market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Pirfenidone is a medication used for the treatment of idiopathic pulmonary fibrosis (IPF), a chronic lung disease that causes scarring and thickening of the lung tissue. Pirfenidone works by reducing lung fibrosis through downregulation of the production of growth factors and procollagens I and II, which are involved in the formation of scar tissue. Pirfenidone is available as a tablet or a capsule, and it is taken orally with food three times a day.
The future market trends of Pirfenidone are expected to be influenced by the following factors:The increasing prevalence of IPF, especially among the elderly population, and the rising awareness and diagnosis of the disease.The growing research and development activities in fibrotic diseases, and the emergence of new drugs and formulations that may offer better efficacy and safety than Pirfenidone.The expansion of the market in emerging regions, such as Asia-Pacific and Latin America, where Pirfenidone has been approved or is under review by regulatory authorities.The impact of the COVID-19 pandemic, which may increase the risk of IPF among patients who have recovered from the infection, and also pose challenges for the supply chain and distribution of Pirfenidone.
LP Information, Inc. (LPI) ' newest research report, the “Pirfenidone Industry Forecast” looks at past sales and reviews total world Pirfenidone sales in 2024, providing a comprehensive analysis by region and market sector of projected Pirfenidone sales for 2025 through 2031. With Pirfenidone sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pirfenidone industry.
This Insight Report provides a comprehensive analysis of the global Pirfenidone landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pirfenidone portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pirfenidone market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pirfenidone and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pirfenidone.
This report presents a comprehensive overview, market shares, and growth opportunities of Pirfenidone market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Pirfenidone market?
What factors are driving Pirfenidone market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pirfenidone market opportunities vary by end market size?
How does Pirfenidone break out by Type, by Application?
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Pirfenidone is a medication used for the treatment of idiopathic pulmonary fibrosis (IPF), a chronic lung disease that causes scarring and thickening of the lung tissue. Pirfenidone works by reducing lung fibrosis through downregulation of the production of growth factors and procollagens I and II, which are involved in the formation of scar tissue. Pirfenidone is available as a tablet or a capsule, and it is taken orally with food three times a day.
The future market trends of Pirfenidone are expected to be influenced by the following factors:The increasing prevalence of IPF, especially among the elderly population, and the rising awareness and diagnosis of the disease.The growing research and development activities in fibrotic diseases, and the emergence of new drugs and formulations that may offer better efficacy and safety than Pirfenidone.The expansion of the market in emerging regions, such as Asia-Pacific and Latin America, where Pirfenidone has been approved or is under review by regulatory authorities.The impact of the COVID-19 pandemic, which may increase the risk of IPF among patients who have recovered from the infection, and also pose challenges for the supply chain and distribution of Pirfenidone.
LP Information, Inc. (LPI) ' newest research report, the “Pirfenidone Industry Forecast” looks at past sales and reviews total world Pirfenidone sales in 2024, providing a comprehensive analysis by region and market sector of projected Pirfenidone sales for 2025 through 2031. With Pirfenidone sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pirfenidone industry.
This Insight Report provides a comprehensive analysis of the global Pirfenidone landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pirfenidone portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pirfenidone market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pirfenidone and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pirfenidone.
This report presents a comprehensive overview, market shares, and growth opportunities of Pirfenidone market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Tablet
- Capsule
- Others
- Mild Idiopathic Pulmonary Fibrosis
- Moderate Idiopathic Pulmonary Fibrosis
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Genentech (Roche)
- Shionogi
- GNI Group
- Beijing Continent
- Cipla
- Lupin Ltd
- Zydus Cadila
- Glenmark Pharmaceuticals
- Koye Pharmaceuticals
- MSN Laboratories
- Wockhardt
- Incepta Pharmaceuticals
- Unimed Unihealth
What is the 10-year outlook for the global Pirfenidone market?
What factors are driving Pirfenidone market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pirfenidone market opportunities vary by end market size?
How does Pirfenidone break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pirfenidone Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Pirfenidone by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Pirfenidone by Country/Region, 2020, 2024 & 2031
2.2 Pirfenidone Segment by Type
2.2.1 Tablet
2.2.2 Capsule
2.2.3 Others
2.3 Pirfenidone Sales by Type
2.3.1 Global Pirfenidone Sales Market Share by Type (2020-2025)
2.3.2 Global Pirfenidone Revenue and Market Share by Type (2020-2025)
2.3.3 Global Pirfenidone Sale Price by Type (2020-2025)
2.4 Pirfenidone Segment by Application
2.4.1 Mild Idiopathic Pulmonary Fibrosis
2.4.2 Moderate Idiopathic Pulmonary Fibrosis
2.4.3 Others
2.5 Pirfenidone Sales by Application
2.5.1 Global Pirfenidone Sale Market Share by Application (2020-2025)
2.5.2 Global Pirfenidone Revenue and Market Share by Application (2020-2025)
2.5.3 Global Pirfenidone Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Pirfenidone Breakdown Data by Company
3.1.1 Global Pirfenidone Annual Sales by Company (2020-2025)
3.1.2 Global Pirfenidone Sales Market Share by Company (2020-2025)
3.2 Global Pirfenidone Annual Revenue by Company (2020-2025)
3.2.1 Global Pirfenidone Revenue by Company (2020-2025)
3.2.2 Global Pirfenidone Revenue Market Share by Company (2020-2025)
3.3 Global Pirfenidone Sale Price by Company
3.4 Key Manufacturers Pirfenidone Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pirfenidone Product Location Distribution
3.4.2 Players Pirfenidone Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PIRFENIDONE BY GEOGRAPHIC REGION
4.1 World Historic Pirfenidone Market Size by Geographic Region (2020-2025)
4.1.1 Global Pirfenidone Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Pirfenidone Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Pirfenidone Market Size by Country/Region (2020-2025)
4.2.1 Global Pirfenidone Annual Sales by Country/Region (2020-2025)
4.2.2 Global Pirfenidone Annual Revenue by Country/Region (2020-2025)
4.3 Americas Pirfenidone Sales Growth
4.4 APAC Pirfenidone Sales Growth
4.5 Europe Pirfenidone Sales Growth
4.6 Middle East & Africa Pirfenidone Sales Growth
5 AMERICAS
5.1 Americas Pirfenidone Sales by Country
5.1.1 Americas Pirfenidone Sales by Country (2020-2025)
5.1.2 Americas Pirfenidone Revenue by Country (2020-2025)
5.2 Americas Pirfenidone Sales by Type (2020-2025)
5.3 Americas Pirfenidone Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pirfenidone Sales by Region
6.1.1 APAC Pirfenidone Sales by Region (2020-2025)
6.1.2 APAC Pirfenidone Revenue by Region (2020-2025)
6.2 APAC Pirfenidone Sales by Type (2020-2025)
6.3 APAC Pirfenidone Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Pirfenidone by Country
7.1.1 Europe Pirfenidone Sales by Country (2020-2025)
7.1.2 Europe Pirfenidone Revenue by Country (2020-2025)
7.2 Europe Pirfenidone Sales by Type (2020-2025)
7.3 Europe Pirfenidone Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pirfenidone by Country
8.1.1 Middle East & Africa Pirfenidone Sales by Country (2020-2025)
8.1.2 Middle East & Africa Pirfenidone Revenue by Country (2020-2025)
8.2 Middle East & Africa Pirfenidone Sales by Type (2020-2025)
8.3 Middle East & Africa Pirfenidone Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pirfenidone
10.3 Manufacturing Process Analysis of Pirfenidone
10.4 Industry Chain Structure of Pirfenidone
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pirfenidone Distributors
11.3 Pirfenidone Customer
12 WORLD FORECAST REVIEW FOR PIRFENIDONE BY GEOGRAPHIC REGION
12.1 Global Pirfenidone Market Size Forecast by Region
12.1.1 Global Pirfenidone Forecast by Region (2026-2031)
12.1.2 Global Pirfenidone Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Pirfenidone Forecast by Type (2026-2031)
12.7 Global Pirfenidone Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Genentech (Roche)
13.1.1 Genentech (Roche) Company Information
13.1.2 Genentech (Roche) Pirfenidone Product Portfolios and Specifications
13.1.3 Genentech (Roche) Pirfenidone Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Genentech (Roche) Main Business Overview
13.1.5 Genentech (Roche) Latest Developments
13.2 Shionogi
13.2.1 Shionogi Company Information
13.2.2 Shionogi Pirfenidone Product Portfolios and Specifications
13.2.3 Shionogi Pirfenidone Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Shionogi Main Business Overview
13.2.5 Shionogi Latest Developments
13.3 GNI Group
13.3.1 GNI Group Company Information
13.3.2 GNI Group Pirfenidone Product Portfolios and Specifications
13.3.3 GNI Group Pirfenidone Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 GNI Group Main Business Overview
13.3.5 GNI Group Latest Developments
13.4 Beijing Continent
13.4.1 Beijing Continent Company Information
13.4.2 Beijing Continent Pirfenidone Product Portfolios and Specifications
13.4.3 Beijing Continent Pirfenidone Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Beijing Continent Main Business Overview
13.4.5 Beijing Continent Latest Developments
13.5 Cipla
13.5.1 Cipla Company Information
13.5.2 Cipla Pirfenidone Product Portfolios and Specifications
13.5.3 Cipla Pirfenidone Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Cipla Main Business Overview
13.5.5 Cipla Latest Developments
13.6 Lupin Ltd
13.6.1 Lupin Ltd Company Information
13.6.2 Lupin Ltd Pirfenidone Product Portfolios and Specifications
13.6.3 Lupin Ltd Pirfenidone Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Lupin Ltd Main Business Overview
13.6.5 Lupin Ltd Latest Developments
13.7 Zydus Cadila
13.7.1 Zydus Cadila Company Information
13.7.2 Zydus Cadila Pirfenidone Product Portfolios and Specifications
13.7.3 Zydus Cadila Pirfenidone Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Zydus Cadila Main Business Overview
13.7.5 Zydus Cadila Latest Developments
13.8 Glenmark Pharmaceuticals
13.8.1 Glenmark Pharmaceuticals Company Information
13.8.2 Glenmark Pharmaceuticals Pirfenidone Product Portfolios and Specifications
13.8.3 Glenmark Pharmaceuticals Pirfenidone Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Glenmark Pharmaceuticals Main Business Overview
13.8.5 Glenmark Pharmaceuticals Latest Developments
13.9 Koye Pharmaceuticals
13.9.1 Koye Pharmaceuticals Company Information
13.9.2 Koye Pharmaceuticals Pirfenidone Product Portfolios and Specifications
13.9.3 Koye Pharmaceuticals Pirfenidone Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Koye Pharmaceuticals Main Business Overview
13.9.5 Koye Pharmaceuticals Latest Developments
13.10 MSN Laboratories
13.10.1 MSN Laboratories Company Information
13.10.2 MSN Laboratories Pirfenidone Product Portfolios and Specifications
13.10.3 MSN Laboratories Pirfenidone Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 MSN Laboratories Main Business Overview
13.10.5 MSN Laboratories Latest Developments
13.11 Wockhardt
13.11.1 Wockhardt Company Information
13.11.2 Wockhardt Pirfenidone Product Portfolios and Specifications
13.11.3 Wockhardt Pirfenidone Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Wockhardt Main Business Overview
13.11.5 Wockhardt Latest Developments
13.12 Incepta Pharmaceuticals
13.12.1 Incepta Pharmaceuticals Company Information
13.12.2 Incepta Pharmaceuticals Pirfenidone Product Portfolios and Specifications
13.12.3 Incepta Pharmaceuticals Pirfenidone Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Incepta Pharmaceuticals Main Business Overview
13.12.5 Incepta Pharmaceuticals Latest Developments
13.13 Unimed Unihealth
13.13.1 Unimed Unihealth Company Information
13.13.2 Unimed Unihealth Pirfenidone Product Portfolios and Specifications
13.13.3 Unimed Unihealth Pirfenidone Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Unimed Unihealth Main Business Overview
13.13.5 Unimed Unihealth Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pirfenidone Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Pirfenidone by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Pirfenidone by Country/Region, 2020, 2024 & 2031
2.2 Pirfenidone Segment by Type
2.2.1 Tablet
2.2.2 Capsule
2.2.3 Others
2.3 Pirfenidone Sales by Type
2.3.1 Global Pirfenidone Sales Market Share by Type (2020-2025)
2.3.2 Global Pirfenidone Revenue and Market Share by Type (2020-2025)
2.3.3 Global Pirfenidone Sale Price by Type (2020-2025)
2.4 Pirfenidone Segment by Application
2.4.1 Mild Idiopathic Pulmonary Fibrosis
2.4.2 Moderate Idiopathic Pulmonary Fibrosis
2.4.3 Others
2.5 Pirfenidone Sales by Application
2.5.1 Global Pirfenidone Sale Market Share by Application (2020-2025)
2.5.2 Global Pirfenidone Revenue and Market Share by Application (2020-2025)
2.5.3 Global Pirfenidone Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Pirfenidone Breakdown Data by Company
3.1.1 Global Pirfenidone Annual Sales by Company (2020-2025)
3.1.2 Global Pirfenidone Sales Market Share by Company (2020-2025)
3.2 Global Pirfenidone Annual Revenue by Company (2020-2025)
3.2.1 Global Pirfenidone Revenue by Company (2020-2025)
3.2.2 Global Pirfenidone Revenue Market Share by Company (2020-2025)
3.3 Global Pirfenidone Sale Price by Company
3.4 Key Manufacturers Pirfenidone Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pirfenidone Product Location Distribution
3.4.2 Players Pirfenidone Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PIRFENIDONE BY GEOGRAPHIC REGION
4.1 World Historic Pirfenidone Market Size by Geographic Region (2020-2025)
4.1.1 Global Pirfenidone Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Pirfenidone Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Pirfenidone Market Size by Country/Region (2020-2025)
4.2.1 Global Pirfenidone Annual Sales by Country/Region (2020-2025)
4.2.2 Global Pirfenidone Annual Revenue by Country/Region (2020-2025)
4.3 Americas Pirfenidone Sales Growth
4.4 APAC Pirfenidone Sales Growth
4.5 Europe Pirfenidone Sales Growth
4.6 Middle East & Africa Pirfenidone Sales Growth
5 AMERICAS
5.1 Americas Pirfenidone Sales by Country
5.1.1 Americas Pirfenidone Sales by Country (2020-2025)
5.1.2 Americas Pirfenidone Revenue by Country (2020-2025)
5.2 Americas Pirfenidone Sales by Type (2020-2025)
5.3 Americas Pirfenidone Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pirfenidone Sales by Region
6.1.1 APAC Pirfenidone Sales by Region (2020-2025)
6.1.2 APAC Pirfenidone Revenue by Region (2020-2025)
6.2 APAC Pirfenidone Sales by Type (2020-2025)
6.3 APAC Pirfenidone Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Pirfenidone by Country
7.1.1 Europe Pirfenidone Sales by Country (2020-2025)
7.1.2 Europe Pirfenidone Revenue by Country (2020-2025)
7.2 Europe Pirfenidone Sales by Type (2020-2025)
7.3 Europe Pirfenidone Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pirfenidone by Country
8.1.1 Middle East & Africa Pirfenidone Sales by Country (2020-2025)
8.1.2 Middle East & Africa Pirfenidone Revenue by Country (2020-2025)
8.2 Middle East & Africa Pirfenidone Sales by Type (2020-2025)
8.3 Middle East & Africa Pirfenidone Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pirfenidone
10.3 Manufacturing Process Analysis of Pirfenidone
10.4 Industry Chain Structure of Pirfenidone
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pirfenidone Distributors
11.3 Pirfenidone Customer
12 WORLD FORECAST REVIEW FOR PIRFENIDONE BY GEOGRAPHIC REGION
12.1 Global Pirfenidone Market Size Forecast by Region
12.1.1 Global Pirfenidone Forecast by Region (2026-2031)
12.1.2 Global Pirfenidone Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Pirfenidone Forecast by Type (2026-2031)
12.7 Global Pirfenidone Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Genentech (Roche)
13.1.1 Genentech (Roche) Company Information
13.1.2 Genentech (Roche) Pirfenidone Product Portfolios and Specifications
13.1.3 Genentech (Roche) Pirfenidone Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Genentech (Roche) Main Business Overview
13.1.5 Genentech (Roche) Latest Developments
13.2 Shionogi
13.2.1 Shionogi Company Information
13.2.2 Shionogi Pirfenidone Product Portfolios and Specifications
13.2.3 Shionogi Pirfenidone Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Shionogi Main Business Overview
13.2.5 Shionogi Latest Developments
13.3 GNI Group
13.3.1 GNI Group Company Information
13.3.2 GNI Group Pirfenidone Product Portfolios and Specifications
13.3.3 GNI Group Pirfenidone Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 GNI Group Main Business Overview
13.3.5 GNI Group Latest Developments
13.4 Beijing Continent
13.4.1 Beijing Continent Company Information
13.4.2 Beijing Continent Pirfenidone Product Portfolios and Specifications
13.4.3 Beijing Continent Pirfenidone Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Beijing Continent Main Business Overview
13.4.5 Beijing Continent Latest Developments
13.5 Cipla
13.5.1 Cipla Company Information
13.5.2 Cipla Pirfenidone Product Portfolios and Specifications
13.5.3 Cipla Pirfenidone Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Cipla Main Business Overview
13.5.5 Cipla Latest Developments
13.6 Lupin Ltd
13.6.1 Lupin Ltd Company Information
13.6.2 Lupin Ltd Pirfenidone Product Portfolios and Specifications
13.6.3 Lupin Ltd Pirfenidone Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Lupin Ltd Main Business Overview
13.6.5 Lupin Ltd Latest Developments
13.7 Zydus Cadila
13.7.1 Zydus Cadila Company Information
13.7.2 Zydus Cadila Pirfenidone Product Portfolios and Specifications
13.7.3 Zydus Cadila Pirfenidone Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Zydus Cadila Main Business Overview
13.7.5 Zydus Cadila Latest Developments
13.8 Glenmark Pharmaceuticals
13.8.1 Glenmark Pharmaceuticals Company Information
13.8.2 Glenmark Pharmaceuticals Pirfenidone Product Portfolios and Specifications
13.8.3 Glenmark Pharmaceuticals Pirfenidone Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Glenmark Pharmaceuticals Main Business Overview
13.8.5 Glenmark Pharmaceuticals Latest Developments
13.9 Koye Pharmaceuticals
13.9.1 Koye Pharmaceuticals Company Information
13.9.2 Koye Pharmaceuticals Pirfenidone Product Portfolios and Specifications
13.9.3 Koye Pharmaceuticals Pirfenidone Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Koye Pharmaceuticals Main Business Overview
13.9.5 Koye Pharmaceuticals Latest Developments
13.10 MSN Laboratories
13.10.1 MSN Laboratories Company Information
13.10.2 MSN Laboratories Pirfenidone Product Portfolios and Specifications
13.10.3 MSN Laboratories Pirfenidone Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 MSN Laboratories Main Business Overview
13.10.5 MSN Laboratories Latest Developments
13.11 Wockhardt
13.11.1 Wockhardt Company Information
13.11.2 Wockhardt Pirfenidone Product Portfolios and Specifications
13.11.3 Wockhardt Pirfenidone Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Wockhardt Main Business Overview
13.11.5 Wockhardt Latest Developments
13.12 Incepta Pharmaceuticals
13.12.1 Incepta Pharmaceuticals Company Information
13.12.2 Incepta Pharmaceuticals Pirfenidone Product Portfolios and Specifications
13.12.3 Incepta Pharmaceuticals Pirfenidone Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Incepta Pharmaceuticals Main Business Overview
13.12.5 Incepta Pharmaceuticals Latest Developments
13.13 Unimed Unihealth
13.13.1 Unimed Unihealth Company Information
13.13.2 Unimed Unihealth Pirfenidone Product Portfolios and Specifications
13.13.3 Unimed Unihealth Pirfenidone Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Unimed Unihealth Main Business Overview
13.13.5 Unimed Unihealth Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Pirfenidone Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Pirfenidone Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players ofTablet
Table 4. Major Players of Capsule
Table 5. Major Players of Others
Table 6. Global Pirfenidone Sales by Type (2020-2025) & (K Pcs)
Table 7. Global Pirfenidone Sales Market Share by Type (2020-2025)
Table 8. Global Pirfenidone Revenue by Type (2020-2025) & ($ million)
Table 9. Global Pirfenidone Revenue Market Share by Type (2020-2025)
Table 10. Global Pirfenidone Sale Price by Type (2020-2025) & (USD/Pcs)
Table 11. Global Pirfenidone Sale by Application (2020-2025) & (K Pcs)
Table 12. Global Pirfenidone Sale Market Share by Application (2020-2025)
Table 13. Global Pirfenidone Revenue by Application (2020-2025) & ($ million)
Table 14. Global Pirfenidone Revenue Market Share by Application (2020-2025)
Table 15. Global Pirfenidone Sale Price by Application (2020-2025) & (USD/Pcs)
Table 16. Global Pirfenidone Sales by Company (2020-2025) & (K Pcs)
Table 17. Global Pirfenidone Sales Market Share by Company (2020-2025)
Table 18. Global Pirfenidone Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Pirfenidone Revenue Market Share by Company (2020-2025)
Table 20. Global Pirfenidone Sale Price by Company (2020-2025) & (USD/Pcs)
Table 21. Key Manufacturers Pirfenidone Producing Area Distribution and Sales Area
Table 22. Players Pirfenidone Products Offered
Table 23. Pirfenidone Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Pirfenidone Sales by Geographic Region (2020-2025) & (K Pcs)
Table 27. Global Pirfenidone Sales Market Share Geographic Region (2020-2025)
Table 28. Global Pirfenidone Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Pirfenidone Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Pirfenidone Sales by Country/Region (2020-2025) & (K Pcs)
Table 31. Global Pirfenidone Sales Market Share by Country/Region (2020-2025)
Table 32. Global Pirfenidone Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Pirfenidone Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Pirfenidone Sales by Country (2020-2025) & (K Pcs)
Table 35. Americas Pirfenidone Sales Market Share by Country (2020-2025)
Table 36. Americas Pirfenidone Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Pirfenidone Sales by Type (2020-2025) & (K Pcs)
Table 38. Americas Pirfenidone Sales by Application (2020-2025) & (K Pcs)
Table 39. APAC Pirfenidone Sales by Region (2020-2025) & (K Pcs)
Table 40. APAC Pirfenidone Sales Market Share by Region (2020-2025)
Table 41. APAC Pirfenidone Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Pirfenidone Sales by Type (2020-2025) & (K Pcs)
Table 43. APAC Pirfenidone Sales by Application (2020-2025) & (K Pcs)
Table 44. Europe Pirfenidone Sales by Country (2020-2025) & (K Pcs)
Table 45. Europe Pirfenidone Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Pirfenidone Sales by Type (2020-2025) & (K Pcs)
Table 47. Europe Pirfenidone Sales by Application (2020-2025) & (K Pcs)
Table 48. Middle East & Africa Pirfenidone Sales by Country (2020-2025) & (K Pcs)
Table 49. Middle East & Africa Pirfenidone Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Pirfenidone Sales by Type (2020-2025) & (K Pcs)
Table 51. Middle East & Africa Pirfenidone Sales by Application (2020-2025) & (K Pcs)
Table 52. Key Market Drivers & Growth Opportunities of Pirfenidone
Table 53. Key Market Challenges & Risks of Pirfenidone
Table 54. Key Industry Trends of Pirfenidone
Table 55. Pirfenidone Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Pirfenidone Distributors List
Table 58. Pirfenidone Customer List
Table 59. Global Pirfenidone Sales Forecast by Region (2026-2031) & (K Pcs)
Table 60. Global Pirfenidone Revenue Forecast by Region (2026-2031) & ($ millions)
Table 61. Americas Pirfenidone Sales Forecast by Country (2026-2031) & (K Pcs)
Table 62. Americas Pirfenidone Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 63. APAC Pirfenidone Sales Forecast by Region (2026-2031) & (K Pcs)
Table 64. APAC Pirfenidone Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 65. Europe Pirfenidone Sales Forecast by Country (2026-2031) & (K Pcs)
Table 66. Europe Pirfenidone Revenue Forecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Pirfenidone Sales Forecast by Country (2026-2031) & (K Pcs)
Table 68. Middle East & Africa Pirfenidone Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Global Pirfenidone Sales Forecast by Type (2026-2031) & (K Pcs)
Table 70. Global Pirfenidone Revenue Forecast by Type (2026-2031) & ($ millions)
Table 71. Global Pirfenidone Sales Forecast by Application (2026-2031) & (K Pcs)
Table 72. Global Pirfenidone Revenue Forecast by Application (2026-2031) & ($ millions)
Table 73. Genentech (Roche) Basic Information, Pirfenidone Manufacturing Base, Sales Area and Its Competitors
Table 74. Genentech (Roche) Pirfenidone Product Portfolios and Specifications
Table 75. Genentech (Roche) Pirfenidone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 76. Genentech (Roche) Main Business
Table 77. Genentech (Roche) Latest Developments
Table 78. Shionogi Basic Information, Pirfenidone Manufacturing Base, Sales Area and Its Competitors
Table 79. Shionogi Pirfenidone Product Portfolios and Specifications
Table 80. Shionogi Pirfenidone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 81. Shionogi Main Business
Table 82. Shionogi Latest Developments
Table 83. GNI Group Basic Information, Pirfenidone Manufacturing Base, Sales Area and Its Competitors
Table 84. GNI Group Pirfenidone Product Portfolios and Specifications
Table 85. GNI Group Pirfenidone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 86. GNI Group Main Business
Table 87. GNI Group Latest Developments
Table 88. Beijing Continent Basic Information, Pirfenidone Manufacturing Base, Sales Area and Its Competitors
Table 89. Beijing Continent Pirfenidone Product Portfolios and Specifications
Table 90. Beijing Continent Pirfenidone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 91. Beijing Continent Main Business
Table 92. Beijing Continent Latest Developments
Table 93. Cipla Basic Information, Pirfenidone Manufacturing Base, Sales Area and Its Competitors
Table 94. Cipla Pirfenidone Product Portfolios and Specifications
Table 95. Cipla Pirfenidone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 96. Cipla Main Business
Table 97. Cipla Latest Developments
Table 98. Lupin Ltd Basic Information, Pirfenidone Manufacturing Base, Sales Area and Its Competitors
Table 99. Lupin Ltd Pirfenidone Product Portfolios and Specifications
Table 100. Lupin Ltd Pirfenidone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 101. Lupin Ltd Main Business
Table 102. Lupin Ltd Latest Developments
Table 103. Zydus Cadila Basic Information, Pirfenidone Manufacturing Base, Sales Area and Its Competitors
Table 104. Zydus Cadila Pirfenidone Product Portfolios and Specifications
Table 105. Zydus Cadila Pirfenidone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 106. Zydus Cadila Main Business
Table 107. Zydus Cadila Latest Developments
Table 108. Glenmark Pharmaceuticals Basic Information, Pirfenidone Manufacturing Base, Sales Area and Its Competitors
Table 109. Glenmark Pharmaceuticals Pirfenidone Product Portfolios and Specifications
Table 110. Glenmark Pharmaceuticals Pirfenidone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 111. Glenmark Pharmaceuticals Main Business
Table 112. Glenmark Pharmaceuticals Latest Developments
Table 113. Koye Pharmaceuticals Basic Information, Pirfenidone Manufacturing Base, Sales Area and Its Competitors
Table 114. Koye Pharmaceuticals Pirfenidone Product Portfolios and Specifications
Table 115. Koye Pharmaceuticals Pirfenidone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 116. Koye Pharmaceuticals Main Business
Table 117. Koye Pharmaceuticals Latest Developments
Table 118. MSN Laboratories Basic Information, Pirfenidone Manufacturing Base, Sales Area and Its Competitors
Table 119. MSN Laboratories Pirfenidone Product Portfolios and Specifications
Table 120. MSN Laboratories Pirfenidone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 121. MSN Laboratories Main Business
Table 122. MSN Laboratories Latest Developments
Table 123. Wockhardt Basic Information, Pirfenidone Manufacturing Base, Sales Area and Its Competitors
Table 124. Wockhardt Pirfenidone Product Portfolios and Specifications
Table 125. Wockhardt Pirfenidone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 126. Wockhardt Main Business
Table 127. Wockhardt Latest Developments
Table 128. Incepta Pharmaceuticals Basic Information, Pirfenidone Manufacturing Base, Sales Area and Its Competitors
Table 129. Incepta Pharmaceuticals Pirfenidone Product Portfolios and Specifications
Table 130. Incepta Pharmaceuticals Pirfenidone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 131. Incepta Pharmaceuticals Main Business
Table 132. Incepta Pharmaceuticals Latest Developments
Table 133. Unimed Unihealth Basic Information, Pirfenidone Manufacturing Base, Sales Area and Its Competitors
Table 134. Unimed Unihealth Pirfenidone Product Portfolios and Specifications
Table 135. Unimed Unihealth Pirfenidone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 136. Unimed Unihealth Main Business
Table 137. Unimed Unihealth Latest Developments
Table 1. Pirfenidone Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Pirfenidone Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players ofTablet
Table 4. Major Players of Capsule
Table 5. Major Players of Others
Table 6. Global Pirfenidone Sales by Type (2020-2025) & (K Pcs)
Table 7. Global Pirfenidone Sales Market Share by Type (2020-2025)
Table 8. Global Pirfenidone Revenue by Type (2020-2025) & ($ million)
Table 9. Global Pirfenidone Revenue Market Share by Type (2020-2025)
Table 10. Global Pirfenidone Sale Price by Type (2020-2025) & (USD/Pcs)
Table 11. Global Pirfenidone Sale by Application (2020-2025) & (K Pcs)
Table 12. Global Pirfenidone Sale Market Share by Application (2020-2025)
Table 13. Global Pirfenidone Revenue by Application (2020-2025) & ($ million)
Table 14. Global Pirfenidone Revenue Market Share by Application (2020-2025)
Table 15. Global Pirfenidone Sale Price by Application (2020-2025) & (USD/Pcs)
Table 16. Global Pirfenidone Sales by Company (2020-2025) & (K Pcs)
Table 17. Global Pirfenidone Sales Market Share by Company (2020-2025)
Table 18. Global Pirfenidone Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Pirfenidone Revenue Market Share by Company (2020-2025)
Table 20. Global Pirfenidone Sale Price by Company (2020-2025) & (USD/Pcs)
Table 21. Key Manufacturers Pirfenidone Producing Area Distribution and Sales Area
Table 22. Players Pirfenidone Products Offered
Table 23. Pirfenidone Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Pirfenidone Sales by Geographic Region (2020-2025) & (K Pcs)
Table 27. Global Pirfenidone Sales Market Share Geographic Region (2020-2025)
Table 28. Global Pirfenidone Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Pirfenidone Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Pirfenidone Sales by Country/Region (2020-2025) & (K Pcs)
Table 31. Global Pirfenidone Sales Market Share by Country/Region (2020-2025)
Table 32. Global Pirfenidone Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Pirfenidone Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Pirfenidone Sales by Country (2020-2025) & (K Pcs)
Table 35. Americas Pirfenidone Sales Market Share by Country (2020-2025)
Table 36. Americas Pirfenidone Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Pirfenidone Sales by Type (2020-2025) & (K Pcs)
Table 38. Americas Pirfenidone Sales by Application (2020-2025) & (K Pcs)
Table 39. APAC Pirfenidone Sales by Region (2020-2025) & (K Pcs)
Table 40. APAC Pirfenidone Sales Market Share by Region (2020-2025)
Table 41. APAC Pirfenidone Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Pirfenidone Sales by Type (2020-2025) & (K Pcs)
Table 43. APAC Pirfenidone Sales by Application (2020-2025) & (K Pcs)
Table 44. Europe Pirfenidone Sales by Country (2020-2025) & (K Pcs)
Table 45. Europe Pirfenidone Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Pirfenidone Sales by Type (2020-2025) & (K Pcs)
Table 47. Europe Pirfenidone Sales by Application (2020-2025) & (K Pcs)
Table 48. Middle East & Africa Pirfenidone Sales by Country (2020-2025) & (K Pcs)
Table 49. Middle East & Africa Pirfenidone Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Pirfenidone Sales by Type (2020-2025) & (K Pcs)
Table 51. Middle East & Africa Pirfenidone Sales by Application (2020-2025) & (K Pcs)
Table 52. Key Market Drivers & Growth Opportunities of Pirfenidone
Table 53. Key Market Challenges & Risks of Pirfenidone
Table 54. Key Industry Trends of Pirfenidone
Table 55. Pirfenidone Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Pirfenidone Distributors List
Table 58. Pirfenidone Customer List
Table 59. Global Pirfenidone Sales Forecast by Region (2026-2031) & (K Pcs)
Table 60. Global Pirfenidone Revenue Forecast by Region (2026-2031) & ($ millions)
Table 61. Americas Pirfenidone Sales Forecast by Country (2026-2031) & (K Pcs)
Table 62. Americas Pirfenidone Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 63. APAC Pirfenidone Sales Forecast by Region (2026-2031) & (K Pcs)
Table 64. APAC Pirfenidone Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 65. Europe Pirfenidone Sales Forecast by Country (2026-2031) & (K Pcs)
Table 66. Europe Pirfenidone Revenue Forecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Pirfenidone Sales Forecast by Country (2026-2031) & (K Pcs)
Table 68. Middle East & Africa Pirfenidone Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Global Pirfenidone Sales Forecast by Type (2026-2031) & (K Pcs)
Table 70. Global Pirfenidone Revenue Forecast by Type (2026-2031) & ($ millions)
Table 71. Global Pirfenidone Sales Forecast by Application (2026-2031) & (K Pcs)
Table 72. Global Pirfenidone Revenue Forecast by Application (2026-2031) & ($ millions)
Table 73. Genentech (Roche) Basic Information, Pirfenidone Manufacturing Base, Sales Area and Its Competitors
Table 74. Genentech (Roche) Pirfenidone Product Portfolios and Specifications
Table 75. Genentech (Roche) Pirfenidone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 76. Genentech (Roche) Main Business
Table 77. Genentech (Roche) Latest Developments
Table 78. Shionogi Basic Information, Pirfenidone Manufacturing Base, Sales Area and Its Competitors
Table 79. Shionogi Pirfenidone Product Portfolios and Specifications
Table 80. Shionogi Pirfenidone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 81. Shionogi Main Business
Table 82. Shionogi Latest Developments
Table 83. GNI Group Basic Information, Pirfenidone Manufacturing Base, Sales Area and Its Competitors
Table 84. GNI Group Pirfenidone Product Portfolios and Specifications
Table 85. GNI Group Pirfenidone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 86. GNI Group Main Business
Table 87. GNI Group Latest Developments
Table 88. Beijing Continent Basic Information, Pirfenidone Manufacturing Base, Sales Area and Its Competitors
Table 89. Beijing Continent Pirfenidone Product Portfolios and Specifications
Table 90. Beijing Continent Pirfenidone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 91. Beijing Continent Main Business
Table 92. Beijing Continent Latest Developments
Table 93. Cipla Basic Information, Pirfenidone Manufacturing Base, Sales Area and Its Competitors
Table 94. Cipla Pirfenidone Product Portfolios and Specifications
Table 95. Cipla Pirfenidone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 96. Cipla Main Business
Table 97. Cipla Latest Developments
Table 98. Lupin Ltd Basic Information, Pirfenidone Manufacturing Base, Sales Area and Its Competitors
Table 99. Lupin Ltd Pirfenidone Product Portfolios and Specifications
Table 100. Lupin Ltd Pirfenidone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 101. Lupin Ltd Main Business
Table 102. Lupin Ltd Latest Developments
Table 103. Zydus Cadila Basic Information, Pirfenidone Manufacturing Base, Sales Area and Its Competitors
Table 104. Zydus Cadila Pirfenidone Product Portfolios and Specifications
Table 105. Zydus Cadila Pirfenidone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 106. Zydus Cadila Main Business
Table 107. Zydus Cadila Latest Developments
Table 108. Glenmark Pharmaceuticals Basic Information, Pirfenidone Manufacturing Base, Sales Area and Its Competitors
Table 109. Glenmark Pharmaceuticals Pirfenidone Product Portfolios and Specifications
Table 110. Glenmark Pharmaceuticals Pirfenidone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 111. Glenmark Pharmaceuticals Main Business
Table 112. Glenmark Pharmaceuticals Latest Developments
Table 113. Koye Pharmaceuticals Basic Information, Pirfenidone Manufacturing Base, Sales Area and Its Competitors
Table 114. Koye Pharmaceuticals Pirfenidone Product Portfolios and Specifications
Table 115. Koye Pharmaceuticals Pirfenidone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 116. Koye Pharmaceuticals Main Business
Table 117. Koye Pharmaceuticals Latest Developments
Table 118. MSN Laboratories Basic Information, Pirfenidone Manufacturing Base, Sales Area and Its Competitors
Table 119. MSN Laboratories Pirfenidone Product Portfolios and Specifications
Table 120. MSN Laboratories Pirfenidone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 121. MSN Laboratories Main Business
Table 122. MSN Laboratories Latest Developments
Table 123. Wockhardt Basic Information, Pirfenidone Manufacturing Base, Sales Area and Its Competitors
Table 124. Wockhardt Pirfenidone Product Portfolios and Specifications
Table 125. Wockhardt Pirfenidone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 126. Wockhardt Main Business
Table 127. Wockhardt Latest Developments
Table 128. Incepta Pharmaceuticals Basic Information, Pirfenidone Manufacturing Base, Sales Area and Its Competitors
Table 129. Incepta Pharmaceuticals Pirfenidone Product Portfolios and Specifications
Table 130. Incepta Pharmaceuticals Pirfenidone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 131. Incepta Pharmaceuticals Main Business
Table 132. Incepta Pharmaceuticals Latest Developments
Table 133. Unimed Unihealth Basic Information, Pirfenidone Manufacturing Base, Sales Area and Its Competitors
Table 134. Unimed Unihealth Pirfenidone Product Portfolios and Specifications
Table 135. Unimed Unihealth Pirfenidone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 136. Unimed Unihealth Main Business
Table 137. Unimed Unihealth Latest Developments
LIST OF FIGURES
Figure 1. Picture of Pirfenidone
Figure 2. Pirfenidone Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pirfenidone Sales Growth Rate 2020-2031 (K Pcs)
Figure 7. Global Pirfenidone Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Pirfenidone Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Pirfenidone Sales Market Share by Country/Region (2024)
Figure 10. Pirfenidone Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture ofTablet
Figure 12. Product Picture of Capsule
Figure 13. Product Picture of Others
Figure 14. Global Pirfenidone Sales Market Share by Type in 2025
Figure 15. Global Pirfenidone Revenue Market Share by Type (2020-2025)
Figure 16. Pirfenidone Consumed in Mild Idiopathic Pulmonary Fibrosis
Figure 17. Global Pirfenidone Market: Mild Idiopathic Pulmonary Fibrosis (2020-2025) & (K Pcs)
Figure 18. Pirfenidone Consumed in Moderate Idiopathic Pulmonary Fibrosis
Figure 19. Global Pirfenidone Market: Moderate Idiopathic Pulmonary Fibrosis (2020-2025) & (K Pcs)
Figure 20. Pirfenidone Consumed in Others
Figure 21. Global Pirfenidone Market: Others (2020-2025) & (K Pcs)
Figure 22. Global Pirfenidone Sale Market Share by Application (2024)
Figure 23. Global Pirfenidone Revenue Market Share by Application in 2025
Figure 24. Pirfenidone Sales by Company in 2025 (K Pcs)
Figure 25. Global Pirfenidone Sales Market Share by Company in 2025
Figure 26. Pirfenidone Revenue by Company in 2025 ($ millions)
Figure 27. Global Pirfenidone Revenue Market Share by Company in 2025
Figure 28. Global Pirfenidone Sales Market Share by Geographic Region (2020-2025)
Figure 29. Global Pirfenidone Revenue Market Share by Geographic Region in 2025
Figure 30. Americas Pirfenidone Sales 2020-2025 (K Pcs)
Figure 31. Americas Pirfenidone Revenue 2020-2025 ($ millions)
Figure 32. APAC Pirfenidone Sales 2020-2025 (K Pcs)
Figure 33. APAC Pirfenidone Revenue 2020-2025 ($ millions)
Figure 34. Europe Pirfenidone Sales 2020-2025 (K Pcs)
Figure 35. Europe Pirfenidone Revenue 2020-2025 ($ millions)
Figure 36. Middle East & Africa Pirfenidone Sales 2020-2025 (K Pcs)
Figure 37. Middle East & Africa Pirfenidone Revenue 2020-2025 ($ millions)
Figure 38. Americas Pirfenidone Sales Market Share by Country in 2025
Figure 39. Americas Pirfenidone Revenue Market Share by Country (2020-2025)
Figure 40. Americas Pirfenidone Sales Market Share by Type (2020-2025)
Figure 41. Americas Pirfenidone Sales Market Share by Application (2020-2025)
Figure 42. United States Pirfenidone Revenue Growth 2020-2025 ($ millions)
Figure 43. Canada Pirfenidone Revenue Growth 2020-2025 ($ millions)
Figure 44. Mexico Pirfenidone Revenue Growth 2020-2025 ($ millions)
Figure 45. Brazil Pirfenidone Revenue Growth 2020-2025 ($ millions)
Figure 46. APAC Pirfenidone Sales Market Share by Region in 2025
Figure 47. APAC Pirfenidone Revenue Market Share by Region (2020-2025)
Figure 48. APAC Pirfenidone Sales Market Share by Type (2020-2025)
Figure 49. APAC Pirfenidone Sales Market Share by Application (2020-2025)
Figure 50. China Pirfenidone Revenue Growth 2020-2025 ($ millions)
Figure 51. Japan Pirfenidone Revenue Growth 2020-2025 ($ millions)
Figure 52. South Korea Pirfenidone Revenue Growth 2020-2025 ($ millions)
Figure 53. Southeast Asia Pirfenidone Revenue Growth 2020-2025 ($ millions)
Figure 54. India Pirfenidone Revenue Growth 2020-2025 ($ millions)
Figure 55. Australia Pirfenidone Revenue Growth 2020-2025 ($ millions)
Figure 56. China Taiwan Pirfenidone Revenue Growth 2020-2025 ($ millions)
Figure 57. Europe Pirfenidone Sales Market Share by Country in 2025
Figure 58. Europe Pirfenidone Revenue Market Share by Country (2020-2025)
Figure 59. Europe Pirfenidone Sales Market Share by Type (2020-2025)
Figure 60. Europe Pirfenidone Sales Market Share by Application (2020-2025)
Figure 61. Germany Pirfenidone Revenue Growth 2020-2025 ($ millions)
Figure 62. France Pirfenidone Revenue Growth 2020-2025 ($ millions)
Figure 63. UK Pirfenidone Revenue Growth 2020-2025 ($ millions)
Figure 64. Italy Pirfenidone Revenue Growth 2020-2025 ($ millions)
Figure 65. Russia Pirfenidone Revenue Growth 2020-2025 ($ millions)
Figure 66. Middle East & Africa Pirfenidone Sales Market Share by Country (2020-2025)
Figure 67. Middle East & Africa Pirfenidone Sales Market Share by Type (2020-2025)
Figure 68. Middle East & Africa Pirfenidone Sales Market Share by Application (2020-2025)
Figure 69. Egypt Pirfenidone Revenue Growth 2020-2025 ($ millions)
Figure 70. South Africa Pirfenidone Revenue Growth 2020-2025 ($ millions)
Figure 71. Israel Pirfenidone Revenue Growth 2020-2025 ($ millions)
Figure 72. Turkey Pirfenidone Revenue Growth 2020-2025 ($ millions)
Figure 73. GCC Countries Pirfenidone Revenue Growth 2020-2025 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Pirfenidone in 2025
Figure 75. Manufacturing Process Analysis of Pirfenidone
Figure 76. Industry Chain Structure of Pirfenidone
Figure 77. Channels of Distribution
Figure 78. Global Pirfenidone Sales Market Forecast by Region (2026-2031)
Figure 79. Global Pirfenidone Revenue Market Share Forecast by Region (2026-2031)
Figure 80. Global Pirfenidone Sales Market Share Forecast by Type (2026-2031)
Figure 81. Global Pirfenidone Revenue Market Share Forecast by Type (2026-2031)
Figure 82. Global Pirfenidone Sales Market Share Forecast by Application (2026-2031)
Figure 83. Global Pirfenidone Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Pirfenidone
Figure 2. Pirfenidone Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pirfenidone Sales Growth Rate 2020-2031 (K Pcs)
Figure 7. Global Pirfenidone Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Pirfenidone Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Pirfenidone Sales Market Share by Country/Region (2024)
Figure 10. Pirfenidone Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture ofTablet
Figure 12. Product Picture of Capsule
Figure 13. Product Picture of Others
Figure 14. Global Pirfenidone Sales Market Share by Type in 2025
Figure 15. Global Pirfenidone Revenue Market Share by Type (2020-2025)
Figure 16. Pirfenidone Consumed in Mild Idiopathic Pulmonary Fibrosis
Figure 17. Global Pirfenidone Market: Mild Idiopathic Pulmonary Fibrosis (2020-2025) & (K Pcs)
Figure 18. Pirfenidone Consumed in Moderate Idiopathic Pulmonary Fibrosis
Figure 19. Global Pirfenidone Market: Moderate Idiopathic Pulmonary Fibrosis (2020-2025) & (K Pcs)
Figure 20. Pirfenidone Consumed in Others
Figure 21. Global Pirfenidone Market: Others (2020-2025) & (K Pcs)
Figure 22. Global Pirfenidone Sale Market Share by Application (2024)
Figure 23. Global Pirfenidone Revenue Market Share by Application in 2025
Figure 24. Pirfenidone Sales by Company in 2025 (K Pcs)
Figure 25. Global Pirfenidone Sales Market Share by Company in 2025
Figure 26. Pirfenidone Revenue by Company in 2025 ($ millions)
Figure 27. Global Pirfenidone Revenue Market Share by Company in 2025
Figure 28. Global Pirfenidone Sales Market Share by Geographic Region (2020-2025)
Figure 29. Global Pirfenidone Revenue Market Share by Geographic Region in 2025
Figure 30. Americas Pirfenidone Sales 2020-2025 (K Pcs)
Figure 31. Americas Pirfenidone Revenue 2020-2025 ($ millions)
Figure 32. APAC Pirfenidone Sales 2020-2025 (K Pcs)
Figure 33. APAC Pirfenidone Revenue 2020-2025 ($ millions)
Figure 34. Europe Pirfenidone Sales 2020-2025 (K Pcs)
Figure 35. Europe Pirfenidone Revenue 2020-2025 ($ millions)
Figure 36. Middle East & Africa Pirfenidone Sales 2020-2025 (K Pcs)
Figure 37. Middle East & Africa Pirfenidone Revenue 2020-2025 ($ millions)
Figure 38. Americas Pirfenidone Sales Market Share by Country in 2025
Figure 39. Americas Pirfenidone Revenue Market Share by Country (2020-2025)
Figure 40. Americas Pirfenidone Sales Market Share by Type (2020-2025)
Figure 41. Americas Pirfenidone Sales Market Share by Application (2020-2025)
Figure 42. United States Pirfenidone Revenue Growth 2020-2025 ($ millions)
Figure 43. Canada Pirfenidone Revenue Growth 2020-2025 ($ millions)
Figure 44. Mexico Pirfenidone Revenue Growth 2020-2025 ($ millions)
Figure 45. Brazil Pirfenidone Revenue Growth 2020-2025 ($ millions)
Figure 46. APAC Pirfenidone Sales Market Share by Region in 2025
Figure 47. APAC Pirfenidone Revenue Market Share by Region (2020-2025)
Figure 48. APAC Pirfenidone Sales Market Share by Type (2020-2025)
Figure 49. APAC Pirfenidone Sales Market Share by Application (2020-2025)
Figure 50. China Pirfenidone Revenue Growth 2020-2025 ($ millions)
Figure 51. Japan Pirfenidone Revenue Growth 2020-2025 ($ millions)
Figure 52. South Korea Pirfenidone Revenue Growth 2020-2025 ($ millions)
Figure 53. Southeast Asia Pirfenidone Revenue Growth 2020-2025 ($ millions)
Figure 54. India Pirfenidone Revenue Growth 2020-2025 ($ millions)
Figure 55. Australia Pirfenidone Revenue Growth 2020-2025 ($ millions)
Figure 56. China Taiwan Pirfenidone Revenue Growth 2020-2025 ($ millions)
Figure 57. Europe Pirfenidone Sales Market Share by Country in 2025
Figure 58. Europe Pirfenidone Revenue Market Share by Country (2020-2025)
Figure 59. Europe Pirfenidone Sales Market Share by Type (2020-2025)
Figure 60. Europe Pirfenidone Sales Market Share by Application (2020-2025)
Figure 61. Germany Pirfenidone Revenue Growth 2020-2025 ($ millions)
Figure 62. France Pirfenidone Revenue Growth 2020-2025 ($ millions)
Figure 63. UK Pirfenidone Revenue Growth 2020-2025 ($ millions)
Figure 64. Italy Pirfenidone Revenue Growth 2020-2025 ($ millions)
Figure 65. Russia Pirfenidone Revenue Growth 2020-2025 ($ millions)
Figure 66. Middle East & Africa Pirfenidone Sales Market Share by Country (2020-2025)
Figure 67. Middle East & Africa Pirfenidone Sales Market Share by Type (2020-2025)
Figure 68. Middle East & Africa Pirfenidone Sales Market Share by Application (2020-2025)
Figure 69. Egypt Pirfenidone Revenue Growth 2020-2025 ($ millions)
Figure 70. South Africa Pirfenidone Revenue Growth 2020-2025 ($ millions)
Figure 71. Israel Pirfenidone Revenue Growth 2020-2025 ($ millions)
Figure 72. Turkey Pirfenidone Revenue Growth 2020-2025 ($ millions)
Figure 73. GCC Countries Pirfenidone Revenue Growth 2020-2025 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Pirfenidone in 2025
Figure 75. Manufacturing Process Analysis of Pirfenidone
Figure 76. Industry Chain Structure of Pirfenidone
Figure 77. Channels of Distribution
Figure 78. Global Pirfenidone Sales Market Forecast by Region (2026-2031)
Figure 79. Global Pirfenidone Revenue Market Share Forecast by Region (2026-2031)
Figure 80. Global Pirfenidone Sales Market Share Forecast by Type (2026-2031)
Figure 81. Global Pirfenidone Revenue Market Share Forecast by Type (2026-2031)
Figure 82. Global Pirfenidone Sales Market Share Forecast by Application (2026-2031)
Figure 83. Global Pirfenidone Revenue Market Share Forecast by Application (2026-2031)
